Paris: AstraZeneca Plc said its blood-cancer medicine Calquence failed to help patients hospitalized with respiratory symptoms of Covid-19.
The group of patients taking the drug in addition to standard care didn’t show fewer deaths or respiratory failures, the U.K. drugmaker said in a statement. Details of the intermediate clinical trials will be presented in due course, the company said.
The Astra study is one of many programs to evaluate known treatments — from antiviral drugs to plasma from recovered patients — against the pandemic virus. Other disappointments include Sanofi’s rheumatoid arthritis medicine Kevzara.
Astra also has a Covid vaccine candidate under development with the University of Oxford, as well as a potential antibody treatment for the disease.- Bloomberg
Also read: After Pfizer, now Moderna will be in the spotlight for its Covid vaccine data
Subscribe to our channels on YouTube & Telegram
Why news media is in crisis & How you can fix it
India needs free, fair, non-hyphenated and questioning journalism even more as it faces multiple crises.
But the news media is in a crisis of its own. There have been brutal layoffs and pay-cuts. The best of journalism is shrinking, yielding to crude prime-time spectacle.
ThePrint has the finest young reporters, columnists and editors working for it. Sustaining journalism of this quality needs smart and thinking people like you to pay for it. Whether you live in India or overseas, you can do it here.